Clinical Genomics and Sequencing
Genomics and Disease Risk
Investigation of the impact of genomic variants on response to drug treatment in diverse populations; establishment and implementation of pharmacogenomic-based drug dosing guidelines; and production of evidence-based resources for clinical applications of pharmacogenomics.
Rongling Li, M.D., Ph.D., M.P.H.
Simona Volpi, Ph.D.
Pharmacogenetics, pharmacogenomics, drug gene interactions